Background: Breast magnetic resonance imaging (MRI) has been introduced in the preoperative management of invasive lobular breast cancer (ILC). We analysed if MRI leads to adequate changes in surgical management.
introduction
Invasive lobular breast cancer (ILC) of the breast constitutes 5%-15% of all invasive breast cancers and is the second most malignant breast disease following invasive ductal carcinoma (IDC) with 70%-90% [1] . ILC is more often multifocal and multicentric than IDC [2] . It has been shown that mammography and ultrasound do not detect all lesions; sensitivity for mammography ranges from 34% to 92% and for ultrasound from 69% to 98% [3, 4] . Moreover, tumour size can be underestimated by these two imaging methods [5, 6] . Therefore, magnetic resonance imaging (MRI) has been introduced in breast diagnostics [7] ; especially in the preoperative management of ILC [8] [9] [10] [11] . Breast MRI has a high sensitivity of 93%-100% for ILC lesions [12] and size estimation has been shown to be more exact compared with mammography and/or ultrasound alone [3, 4, 13, 14] .
On the one hand, there is some evidence that ILC patients-based on small studies-showing a benefit due to breast MRI, defined as adequate change of surgical management [14] [15] [16] [17] [18] . Nonetheless, overestimation and subsequent overtreatment following breast MRI may occur [4, 14] -even though this seems to be a rare event.
On the other hand, there is no empirical evidence for breast cancer patients in general that suggests the implementation of a preoperative breast MRI with a subsequent more adequate surgical management that actually changes long-term outcomes such as local recurrences, distant-free and overall survival [13] . The prospective randomised COMICE trial [19] will probably answer this question for the cohort of all breast cancer patients; whether the subgroup analysis of ILC patients in this study has enough power to do the same for this special cohort seems questionable. Based on the biological nature of ILC and the evidence of the different diagnostic performances of the different instruments (mammography, ultrasound and breast MRI), one might argue that those patients with ILC, if any, will potentially benefit the most. At least, this seems to be the argument of national and international guidelines [8] [9] [10] [11] .
Therefore, one might define the adequate change in surgical therapy as the most important surrogate for long-term outcome in ILC patients but must also evaluate overtreatment due to false-positive breast MRI results as well.
patients and methods inclusion and exclusion criteria; description of the study population
We searched the Heidelberg Breast Unit database for all patients with ILC diagnosed by core biopsy and proven by final pathology from 01 January 2007 to 31 December 2009 (n = 206). We excluded patients who underwent neoadjuvant chemotherapy (n = 5) or with recurrent disease (n = 23). Patients who only received mammography and ultrasound alone were also excluded. Reasons for missing breast MRI could have been contraindications of MRI such as metal in the body, claustrophobia, adipositas permagna, patient request not to perform a breast MRI or other unknown reasons (n = 86). Therefore, all consecutive patients with a primary ILC, preoperative breast MRI and surgical therapy at the Heidelberg Breast Unit were included in the analysis (n = 92). Of the patients selected, 42% were treated with wide excision/segmental resection/ lumpectomy, 20% with quadrantectomy and 38% with primary mastectomy (compare Table 1 ).
definitions and study protocol
We applied the following definitions: new suspicious finding. Within this term, we summarised additional suspicious lesions as well as a clinically relevant increase in the size of the index lesion.
Additional suspicious lesion: Lesion with similar morphological and contrast medium kinetic appearance as the index lesion or highly suspicious lesion for malignancy according to the Breast ImagingReporting and Data System (BI-RADS) lexicon for breast MRI [20] . Clinically relevant increase in size of the index lesion: increment of >5 mm in largest diameter in index lesions >20 mm. With respect of index lesions <20 mm in all three diagnostic instruments, we did not consider an increase in size of any magnitude clinically relevant as tumours with <20 mm are generally treated with wide excision/segmental resection/ lumpectomy; whereas tumours >20 mm are operated depending upon breast size or other criteria. surgical procedures. We did not differentiate between wide excision, lumpectomy and segmental resection as all these techniques refer to circumscribed breast-conserving procedures. Quadrantectomy was considered to be an extensive breast-conserving technique. The surgical procedures were carried out by certificated breast surgeons (>100 breast surgeries per year).
'real' and blinded (= 'mock') tumour board method. For all cases that showed a new suspicious finding in breast MRI, we carried out a 'mock' interdisciplinary tumour board. Real and blinded ('mock') tumour board (compare Figure 1 ) consisted of the same members: two breast diagnostic specialists (experience 20 years and 5 years), two breast surgeons (experience 10 years and 5 years), a breast pathologist (experience 15 years) and a medical oncologist (experience 5 years); the latter took place 9-36 months after the real tumour board. As the real board recommended a surgical procedure on a synopsis of ultrasound, mammography and breast MRI, the mock tumour board did the same without the knowledge of the results of the breast MRI. The members of the 'mock' tumour board received anonymous patient data and images and were blinded to all other aspects like aim and content of the study. Afterwards, the authors analysed and compared the recommendations of the mock tumour board with those of the 'real' tumour board.
adequate change of surgical procedure due to breast MRI. If the postoperative pathology findings corresponded better with the results of breast MRI than mammography or ultrasound (i.e. the confirmation of the new suspicious finding), the change in surgical management was meant to be adequate. This situation was defined as a benefit for the patient. Final consensual decision on these cases was carried out by the tumour board members.
MRI technique
Diagnostic breast MRI was carried out on a 1.5 Tesla field scanner (AvantoÒ; Siemens Medical, Erlangen, Germany) using a bilateral breast coil (Seven-channel Biopsy Breast Array, Invivo, Orlando, FL). The investigation was carried out in prone position using a slight compression of the breast. For the analysis, the images were sent to a separate CAD-system (Dynacad, Invivo). The images were interpret by experienced radiologists in breast diagnostics (>100 MRIs per year) applying the BI-RADS classification for a standardised description of the images [10] .
technical specification and interpretation of mammography
Only digital mammography was carried out on either a Siemens Mammomat Novation or a Siemens Mammomat Inspiration (Siemens Medical) on the basis of European guidelines [21] . A daily technical quality control was carried out by the European reference centre of quality control in Leuven (Prof. Hilde Bosmans). The department takes 20 000 mammograms a year. In every case of suspicious findings, mediolateraloblique, a cranio-caudal and medio-lateral views were carried out, combined with spot compression and magnification views whenever necessary. All images were soft-copy double-read by very experienced radiologists in breast diagnostics (breast mammograms >10.000 per year the last 20 years (AH or HJ)) applying the BI-RADS classification [22] .
technical specification and interpretation of ultrasound original articles Annals of Oncology was carried out by at least one experienced physician (>5000 ultrasound examinations a year the last 20 years (AH or HJ)). BI-RADS for ultrasound was always applied [22] . In each case, both breasts were systematically examined. All suspicious lesions were documented in two perpendicular planes.
statistical methods
We carried out a retrospective confirmatory analysis in order to demonstrate that >5% of ILC patients benefit (= adequate change of surgical management) from preoperative breast MRI compared with the use of ultrasound and mammography alone. The corresponding test hypotheses (H0: P £ 0.05 versus H1: P > 0.05) were tested using the normal approximation test for rates for a one-sided significance level of 2.5%. The available sample size of 92 patients would have provided a power of 77% if the actual benefit rate would had been given by 12%. Moreover, we calculated the percentage of patients who were overtreated due to the findings in the supplementary breast MRI and the percentage with no change in therapeutic procedures and their respective two-sided 95% confidence intervals (CIs). In order to find out if there is a subgroup of ILC patients that more likely benefits from a preoperative MRI, we compared the group of patients that benefit from breast MRI with the group consisting of patients with no change in surgical therapy or overtreatment with respect to patient, diagnostic, therapeutic and pathological variables.
The new suspicious findings were collected and described on lesion-level as choosing the patient-level might lead to a considerable loss of power according to a study by Obuchowski et al. [23] .
ethics and patient consent
The study concept has been approved by the ethical committee of the Medical Faculty of the Heidelberg University.
results

new suspicious findings
As displayed in Table 2 , breast MRI revealed a clinically relevant increase in size of the index lesion in 14 patients and showed 10 ipsilateral and 7 contralateral, altogether 17 additional suspicious lesions in 15 patients. Out of 17 new suspicious lesions, 10 underwent biopsy preoperatively and proved to be cancer. The remaining seven lesions were all ascertained as tumours in final pathology. Of the additional lesions, 15 showed an ILC, 1 an IDC and 1 a ductal carcinoma in situ histology. Four times MRI had shown additional suspicious lesions, which were biopsied and revealed to be benign. These additional suspicious lesions were excluded from the further analysis of new suspicious findings by breast MRI.
In summary, breast MRI revealed new suspicious findings in 29 patients (32%; 95% CI 24%-44%), all proven to be cancer, either pre-or postoperatively.
change in surgical therapy
Surgical therapy was changed in 23 of 92 patients (25%) based on new findings by breast MRI. This change was adequate in 20 patients (87%). Thus, the benefit rate was 22% (20 of 92 patients, 95% CI 14%-31%; P < 0.0001).
Three patients (3%) underwent mastectomy due to overestimation of tumour extent by breast MRI even though a breast-conserving therapy would have been possible. Accordingly, the overtreatment rate was 3% (3 of 92 patients, 95% CI 0%-6%). For the three patients with MRI-induced mastectomy, quadrantectomy would have been possible, the tumour either being not multicentric defined as lesions in more than one quadrant of the breast, or being significantly smaller in size than suspected by breast MRI (see Table 3 ).
For six (7%, 95% CI 3%-9%) patients with new suspicious findings, surgical therapy was not changed; the new suspicious findings had no impact on their surgical management.
detailed description of patients with overtreatment Patient 1. The first patient with an unnecessary MRI-induced mastectomy was 65 years old, had bra-size D and breast density was described with ACR II.
Breast MRI had detected an additional suspicious ipsilateral lesion and a clinically relevant increase in size of the index lesion (tumour size 54 mm, multifocal versus 20 mm and unifocal in ultrasound mammography). Final pathology revealed a multifocal tumour with an overall tumour size of 34 mm. Thus, quadrantectomy would have been possible. Patient 2. The second patient with an unnecessary mastectomy was 76 years old, had bra-size B and breast density was given with ACR II.
Again, breast MRI detected a new suspicious additional ipsilateral lesion and a clinically relevant increase in size of the index lesion. Size of the index lesion in primary mammography and ultrasound was given 15 mm respectively versus 30 mm in breast MRI. Furthermore, breast MRI detected satellite lesions, which had not been detected by primary ultrasound or mammography. Subsequently, due to the increase in tumour extent and the additional lesion, mastectomy was recommended. Final pathology revealed two lesions with 25 and 17 mm in the same quadrant. Thus, quadrantectomy would have been possible. Patient 3. This patient was 74 years old, had bra-size C and breast density was indicated with ACR II.
Breast MRI showed an increase in size of the index lesion from 18 mm in mammography and 14 mm in ultrasound to 60 mm in breast MRI and a conversion from unifocal to multifocal. The real tumour board recommended mastectomy after the breast MRI on that side, whereas the mock tumour board suggested segmental resection based on the conventional imaging. One patient showed an additional ipsilateral and an additional contralateral finding.
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Final pathology revealed an overall 25-mm large multifocal tumour and consequently quadrantectomy would have been possible.
Furthermore, breast MRI also detected two new suspicious findings in the contralateral breast. Secondary ultrasound could detect one lesion, which was subsequently biopsied and pathology confirmed an ILC. As the two lesions were situated very close to each other and both visualised as rather small in breast MRI, it was decided to perform a segmental resection on that side. Final pathology of the segmental resection specimen revealed two lesions with 9 and 7 mm.
In conclusion, this patient received an adequate segmental resection on the contralateral side and an inadequate mastectomy on the ipsilateral side of the index lesion. Due to the unilateral unnecessary mastectomy, this patient was counted as a case of overtreatment induced by breast MRI, although breast MRI had also revealed two additional contralateral lesions, which would have otherwise not been detected and treated. Thus, the third patient benefited from both and was harmed by breast MRI.
analysis of the subgroup that benefited
The subgroup analysis revealed a significant difference with respect to tumour size between the patients who benefited from the supplementary preoperative MRI and the patients who did not (P = 0.027). In the benefit group, the pathological T-stage was significantly higher than in the group without benefit. Age, breast sizes and breast density were not significantly different between the groups (see Table 4 ). discussion adequate change in terms of surgical therapy due to a supplementary preoperative breast MRI
We defined an adequate change in surgical therapy due to breast MRI as a benefit for the patients; assuming adequate surgical therapy with complete pathologically confirmed surgical eradication of the tumour to be an important surrogate for secondary surgery rates, local recurrences and possibly overall survival in ILC patients. On the other hand, a large node-positive breast cancer may be the leading prognostic issue compared with a possibly overlooked small ipsilateral or contralateral breast cancer. This question of the clinical significance of MRI-detected lesions can only be addressed by large prospective randomised clinical trials, which are under way [11] . Until then, we need to decide on best evidence of assumed surrogates such as adequate change of surgical management due to breast MRI in ILC patients.
benefit versus overtreatment
Of the patients studied, 22% (95% CI 14%-31%) benefited-according to our definition discussed above-from the implementation of a preoperative breast MRI, whereas 3% (95% CI 0%-6%) were harmed and 75% (95% CI 66%-84%) did not experience any change in surgical therapy. In a systematic review by Mann et al. [13] , including six studies [14] [15] [16] [17] [18] 24] with 20-51 patients (a total of 160 patients), a change in surgical therapy based solely on MRI findings occurred in 44 patients (28%). For 41 patients (88%), the change was considered appropriate. In three cases (12%), the change resulted in overtreatment. Thus, the systematic review reported an overtreatment rate of 2% and the calculated 95% CI would be 0%-4%, reinforcing the results of our study which is the largest of its kind up to date.
limitations of the study
We distinguished between a limited wide excision/segmental resection and a more extensive quadrantectomy. The definitions of these procedures have been consistent as it has been a single-centre study with a small number of breast surgeons (four certified breast surgeons) over a short period of original articles Annals of Oncology time. Furthermore, the differentiation between wide excision and quadrant resection is clinically relevant since it has been hypothesised that a more extensive resection of breast volume leads to poorer aesthetic outcome [25] and therefore results in a lower quality of life [26, 27] . A limitation of our study was that the preoperative recommendations on surgical therapy were not objectively standardised and measurable. In order to counterbalance this, we presented the cases to an identically constituted interdisciplinary conference of specialists in the mock tumour board, demanding consensus for the treatment of each patient. Moreover, none of the other studies dealing with changes in surgical therapy for ILC patients following breast MRI carried out a similar tumour board simulation. They described only vaguely how they decided that a change had been based solely on breast MRI findings [15] [16] [17] [18] .
Another limitation of our study is the selection bias. Of the 178 patients with primary ILC (excluded those of recurrent disease and those after neoadjuvant chemotherapy) a breast MRI was carried only in 92 patients. None of the other retrospective studies [15] [16] [17] [18] even mention these numbers. As this study is not a prospective randomised trial, this causes a selection bias. We know that those patients with breast MRI in preoperative assessment were younger and had denser breasts [28] . Therefore we conclude that we might overestimate the impact of breast MRI in preoperative work-up of ILC.
new suspicious findings
In our study, breast MRI revealed 17 additional suspicious lesions in 15 patients, and a clinically relevant increase in the size of lesions in 14 patients resulting in 29 patients (32%) with clinically relevant new findings following breast MRI. In the literature, different definitions for additional lesions have been applied. Some authors defined additional lesions as all lesions apart from the index lesions detected by conventional work-up; others included lesions with a defined increase in size (varying between study protocols). The review by Mann et al. [13] -summarising all different definitions described above-stated a 32% increase in additional lesions in patients with ILC due to breast MRI and thus supported our result.
The impact of the detection of additional lesions has been controversially discussed: Critics of preoperative breast MRI argue that the surgical treatment of these additional lesions cannot be a crucial factor in surgical treatment of breast cancer. They conclude that radiotherapy eradicates most of the ipsilateral lesions occult in mammography and ultrasound; occult mainly small contralateral lesions do not have any meaning in times of multimodal therapies. On the other hand, in four out of six randomised controlled trials, which compare breast conserving therapy (BCT) vs. mastectomy [29] , the locoregional recurrence was significantly lower in the group with mastectomy than in the group with BCT (odds ratio = 1.56). Moreover, locoregional recurrence could be a predictor for overall survival [30] . Therefore, supporters of breast MRI concluded that the better sensitivity of breast MRI should facilitate complete removal of tumour tissue [31] and in consequence less local recurrences. However, in the randomised COMICE trial [19] , the latter was also refuted for the subgroup of ILC. In order to decide whether breast MRI can reduce recurrence rates or improve survival rates in patients with ILC, long-term follow-up of the prospective randomised trials has to occur.
subgroup analysis
It was possible to show that patients with larger tumours more likely benefited from a preoperative breast MRI. We could not identify any other factors influencing the benefit rate of MRI. Berg et al. [20] carried out a similar correlation analysis in order to find a group of patients who were likely to benefit from preoperative MRI. The authors of the study applied their search to all primary breast cancer patients irrespective of pathological type, but could not find patient characteristics to distinguish the benefiting group from the group without benefit. 
